Skip to content

NMN for Age-Related Cognitive Decline: What the Evidence Actually Shows

Category: neurological | ICD-10: R41.81 | Evidence tier: mechanistic-only

What is Age-Related Cognitive Decline?

Age-related cognitive decline is the gradual slowing of processing speed, memory and executive function that accompanies normal ageing. It is not a disease but is a common reason older Malaysians try supplements.

NMN relevance: the published evidence

Mechanistic data link NAD+ decline to brain ageing. No RCT has shown NMN improves validated cognitive scores in healthy older adults. Sleep, exercise, social engagement, hearing care and cardiovascular health have far stronger evidence.

Questions to ask before supplementing

No dose validated for cognitive performance.

Contraindications and red flags

Sudden cognitive change is not normal ageing - see a doctor.

Bottom line for Malaysian patients

NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have age-related cognitive decline, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.

Related conditions

Cited references